Novartis announced Tuesday that Switzerland's drug regulator, Swissmedic, approved Coartem Baby, the world's first malaria treatment specifically designed for newborns and infants weighing less than five kilograms.
First Malaria Treatment for Newborns Approved by Swiss Regulators